Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Meteospasmyl in Irritable Bowel Syndrome
2007-000060-25Phase 4Completed
- Sponsor
- Mayoly Spindler
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing Meteospasmyl with Placebo (2 arms). Primary endpoint: Improvement in pain/discomfort on VAS at 4 weeks. Started Feb 2007; status: completed.
02
Drugs
alverine citrate + simeticone
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on 2007-000060-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000060-25.